What are the pathophysiology, clinical presentation, diagnostic workup, and management of peripheral artery disease?

Peripheral Artery Disease: Comprehensive Overview

Pathophysiology

PAD results from atherosclerotic narrowing and thrombosis of arteries supplying the lower extremities, creating a chronic ischemic state that impairs tissue perfusion and oxygen delivery 1. The disease affects approximately 230 million people worldwide, with prevalence ranging from 0.9-31.3% in those aged ≥50 years 2. The atherosclerotic process involves lipid accumulation, inflammatory cell infiltration, and plaque formation that progressively narrows arterial lumens, reducing blood flow particularly during exercise when metabolic demands increase 3.

Clinical Presentation and Signs/Symptoms

Only one-third of PAD patients present with typical claudication; most have atypical exertional leg symptoms or are asymptomatic, making careful symptom assessment critical 4.

Classic Claudication Features:

• Reproducible discomfort in specific muscle groups (buttock, thigh, calf)
• Consistently induced by same level of exercise
• Relieved within 10 minutes of rest
• Does not occur at rest

Atypical Presentations:

• Exertional leg fatigue or weakness without pain
• "Masked PAD" - no leg pain due to reduced walking capacity from other causes or diminished pain sensitivity
• Asymptomatic disease detected by absent pulses or imaging

Physical Examination Findings 4:

• Pulse assessment (femoral, popliteal, dorsalis pedis, posterior tibial): Rate as 0=absent, 1=diminished, 2=normal, 3=bounding
  • Presence of all 4 pedal pulses bilaterally suggests low PAD likelihood
• Abdominal or femoral bruits
• Elevation pallor/dependent rubor
• Asymmetric hair growth
• Calf muscle atrophy
• In diabetics: assess for peripheral neuropathy

Critical Differential Diagnoses 4:

The following conditions mimic PAD but have distinct features:

Condition	Location	Character	Key Distinguishing Features
Musculoskeletal	Variable	Aching	Immediate with use, variable relief
Nerve root compression	Radiates down leg	Sharp, lancinating	Worse with sitting, improved by position change
Spinal stenosis	Bilateral buttocks/posterior leg	Pain and weakness	Relief with lumbar flexion, worse standing
Venous claudication	Entire leg	Tight, bursting	Subsides slowly, history of DVT, edema present

Diagnostic Workup

The resting ankle-brachial index (ABI) with or without ankle pulse volume recordings is the recommended initial test to establish PAD diagnosis in patients with suggestive history or examination 4.

ABI Interpretation 4:

• ≤0.90: Abnormal (confirms PAD)
• 0.91-0.99: Borderline
• 1.00-1.40: Normal
• >1.40: Noncompressible (suggests medial arterial calcification, common in diabetes/ESRD)

Diagnostic Algorithm 5:

1. First-line: Resting ABI

   • If ABI >0.90 with high clinical suspicion: perform post-exercise ABI
   • Post-exercise ABI decrease >20% confirms PAD 5

2. For noncompressible vessels (ABI >1.40) 5:

   • Toe-brachial index (TBI)
   • Transcutaneous oxygen pressure (TcPO₂)
   • These are essential in diabetics and CLTI patients

3. Anatomic imaging (when revascularization considered):

   • Duplex ultrasound (DUS): First-line, radiation-free, high sensitivity for ≥50% stenosis, but operator-dependent 6
   • CT angiography (CTA): Rapid, high-resolution, requires contrast and radiation 6
   • MR angiography (MRA): Excellent soft-tissue contrast, no radiation, use noncontrast techniques (QISS) in renal dysfunction 6
   • Digital subtraction angiography (DSA): Gold standard, reserved for intervention planning 6

Screening Indications 4:

Screen with ABI in patients at increased risk:

• Age ≥65 years
• Age 50-64 with atherosclerosis risk factors (diabetes, smoking, hypertension, dyslipidemia)
• Age <50 with diabetes plus one additional risk factor
• Known atherosclerotic disease in other vascular beds

Treatment

All PAD patients require guideline-directed medical therapy (GDMT) including antithrombotic, lipid-lowering, glucose-lowering, and antihypertensive therapies, plus structured exercise 1.

Medical Management

Antithrombotic Therapy 7:

• Clopidogrel preferred as single antiplatelet agent
• Aspirin alternative if clopidogrel contraindicated
• Dual antiplatelet therapy (aspirin + clopidogrel) after revascularization

Lipid Management:

• High-intensity statin for all PAD patients 7
• Target aggressive LDL reduction

Diabetes Management 5:

Prioritize glucose-lowering agents with proven cardiovascular benefit:

• SGLT2 inhibitors (empagliflozin, canagliflozin, dapagliflozin, sotagliflozin) - Class I, Level A recommendation
• GLP-1 receptor agonists (liraglutide, semaglutide, dulaglutide) - Class I, Level A recommendation
• Metformin as adjunct if additional glucose control needed
• Individualize HbA1c targets; avoid hypoglycemia

Blood Pressure Control 7:

• ACE inhibitors or ARBs appropriate
• Beta-blockers not contraindicated despite historical concerns

Smoking Cessation 8:

• Mandatory counseling and pharmacotherapy

Symptom Management

For Claudication 3, 7:

1. Structured exercise therapy (first-line)

   • Supervised programs superior to unsupervised
   • 30-45 minutes, 3+ times weekly
   • Walk to near-maximal pain, rest, repeat

2. Cilostazol (FDA-approved)

   • Phosphodiesterase-3 inhibitor
   • Improves walking distance
   • Contraindicated in heart failure

3. Pentoxifylline (alternative, less effective than cilostazol) 9

Revascularization Indications 1:

Revascularization recommended for:

• Chronic limb-threatening ischemia (CLTI) - compromised limb viability
• Acute limb ischemia - urgent evaluation required 7
• Severe functional impairment not improving with exercise training and medical therapy

Revascularization NOT indicated for:

• Asymptomatic PAD
• Chronic symptomatic PAD responding to medical therapy and exercise

Risk Stratification:

Use WIfI classification (Wound, Ischemia, foot Infection) to assess amputation risk systematically 5

Key Clinical Pitfalls

• Don't dismiss atypical symptoms: Two-thirds of PAD patients lack classic claudication 4
• Don't rely solely on ABI in diabetics: Use TBI or TcPO₂ when ABI >1.40 5
• Don't order anatomic imaging unless revascularization planned: Avoid unnecessary testing in asymptomatic or medically managed patients 4
• Don't forget cardiovascular risk: PAD patients have 4-5× increased risk of MI, stroke, and cardiovascular death 5 - aggressive systemic risk modification is paramount
• Don't overlook exercise therapy: Often underutilized despite being first-line for claudication 3

Multidisciplinary Approach

Given PAD complexity, management requires a multidisciplinary vascular team including primary care, cardiology, vascular surgery, endocrinology, and rehabilitation specialists to achieve optimal individualized outcomes 1.